Tortuga Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$734K Sell
11,762
-1,466
-11% -$92.6K 0.52% 48
2026
Q2
$762K Buy
13,228
+463
+4% +$26.6K 0.58% 46
2026
Q1
$774K Buy
12,765
+1,938
+18% +$113K 0.72% 32
2025
Q4
$584K Buy
+10,827
New +$521K 0.62% 37

Other funds holding BMY

Tortuga Wealth Management's BMY Position: Q3 2026 in Review

Tortuga Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q3 2026, selling an estimated $92.6K and leaving 11,762 shares worth $734K. The position accounts for 0.52% of the portfolio, ranked #48.

Tortuga Wealth Management first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. The position peaked at $774K in Q1 2026. 2,074 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Tortuga Wealth Management held 11,762 shares of Bristol-Myers Squibb worth $734K as of Q3 2026.
  • Tortuga Wealth Management sold 1,466 Bristol-Myers Squibb shares in Q3 2026, an estimated $92.6K.
  • Bristol-Myers Squibb made up 0.52% of Tortuga Wealth Management's portfolio in Q3 2026, its #48 holding.
  • Tortuga Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • Tortuga Wealth Management's Bristol-Myers Squibb position peaked at $774K in Q1 2026.
  • 2,074 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Tortuga Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.